Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: Rationale and design

Background Ischemic stroke and other vascular outcomes occur in 10–20% of patients in the three-months following a transient ischemic attack or minor ischemic stroke, and many are disabling. The highest risk period for these outcomes is the early hours and days immediately following the ischemic eve...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: S. Claiborne Johnston, J. Donald Easton, Mary Farrant, William G. Barsan, Holly Battenhouse, Robin Conwit, Catherine Dillon, Jordan Elm, Anne S. Lindblad, Lewis B. Morgenstern, Sharon N. Poisson, Amy Yu
Formato: Artigo
Idioma:inglés
Publicado: 2013
Acceso en liña:https://doi.org/10.1111/ijs.12129
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!